-
Featured News /
For over 40 years Novartis has been committed to understanding sickle cell disease and working towards treatment.
-
Featured News /
-
Featured News /
Novartis COVID-19 Response Fund is providing urgently-needed support for healthcare workers and communities in over 50 projects around the world.
-
Story /Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.
-
Featured News /
The first pan-African Novartis Social Business stakeholder dialogue took place in Kampala, Uganda, on March 20, 2019.
-
Featured News /
Standing by people with sickle cell disease and their families
-
Story /Advanced Accelerator Applications is working on marrying targeted drug design with nuclear medicine technology to develop drugs that can recognize and treat diseases.
-
Story /University students majoring in the life sciences or business often have trouble imagining the direction of their careers.
-
Featured News /
As a company, we stand up for greater inclusion of LGBTI people because when each of us feels included, we all benefit.
-
Featured News /
The Co-Creating Impact Summit happening on December 9th, 2020, will gather experts inside and outside of Novartis to continue our work of improving our impact on the society and the planet.